181 related articles for article (PubMed ID: 20492471)
1. Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.
Fernandes N; Mosnier LO; Tonnu L; Heeb MJ
J Thromb Haemost; 2010 Sep; 8(9):1976-85. PubMed ID: 20492471
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
3. Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.
Stavenuiter F; Davis NF; Duan E; Gale AJ; Heeb MJ
Thromb Haemost; 2013 Feb; 109(2):229-37. PubMed ID: 23238804
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
Heeb MJ; Prashun D; Griffin JH; Bouma BN
FASEB J; 2009 Jul; 23(7):2244-53. PubMed ID: 19244162
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
6. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
[TBL] [Abstract][Full Text] [Related]
7. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
[TBL] [Abstract][Full Text] [Related]
8. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
9. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
10. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
Ndonwi M; Broze G; Bajaj SP
J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
[TBL] [Abstract][Full Text] [Related]
12. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
[TBL] [Abstract][Full Text] [Related]
13. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
14. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
Lockett JM; Mast AE
Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
[TBL] [Abstract][Full Text] [Related]
15. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
[TBL] [Abstract][Full Text] [Related]
16. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
[TBL] [Abstract][Full Text] [Related]
18. TFPI-dependent activities of protein S.
Peraramelli S; Rosing J; Hackeng TM
Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
[TBL] [Abstract][Full Text] [Related]
19. Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).
Dockal M; Hartmann R; Fries M; Thomassen MC; Heinzmann A; Ehrlich H; Rosing J; Osterkamp F; Polakowski T; Reineke U; Griessner A; Brandstetter H; Scheiflinger F
J Biol Chem; 2014 Jan; 289(3):1732-41. PubMed ID: 24275667
[TBL] [Abstract][Full Text] [Related]
20. The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.
Ndonwi M; Tuley EA; Broze GJ
Blood; 2010 Aug; 116(8):1344-51. PubMed ID: 20479289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]